Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK, Safety, and QT Modelling of Estetrol/Drospirenone in Healthy Women
NCT02874248Phase 1Completed
- Sponsor
- Estetra SRL
- Start
- May 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of estetrol in contraception (8 arms), sponsored by Estetra SRL. Primary endpoints: Maximum observed plasma concentration at Day 28, Time to maximum plasma concentration at Day 28 and 7 more. Started May 2016; status: completed.
02
Drugs
estetrol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT02874248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02874248.